ARCHIVES

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

This article is from The Cancer Letter archive.

Vol. 33 No. 18 | May 11, 2007

Download PDF Visit The Full Archive

Related Articles

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

Radiation Table Recommendations Completed

July 22, 1983

Guest Editorial: Andrew Vickers on PSA Skepticism, Rational and Irrational

October 10, 2014

GM Downsizes “Nobel Prize” For Cancer; Bristol Ends Medical Research Grants and Awards Program.

June 23, 2006

December Business & Regulatory Report included in this issue.

December 12, 2003

Firm To Collaborate With R. W. Johnson On Vaccines.

December 1, 2000